We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » FDAnews Books Library » Files

FDAnews Books Library

 

Gain Access to All Books and Reports

Our Books Library gives you year-round unrestricted access to all our books and reports.

They can be accessed, searched, downloaded and read anywhere, anytime. Topics covered include inspections, auditing, validation, recalls, pharmacovigilance, biosimilars, adverse events, QSR Data, supply chain, financial disclosure requirements and much more. You’ll automatically receive every new book we publish — we'll send you notifications to alert you of each new book in the library.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $997

Also available: Take advantage of our multi-user and site licenses of the FDAnews Books Library so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword (title of book maybe) or simply scroll through the list of titles to find what you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

GCP Questions, FDA Answers - 2021 Edition

May 13, 2021
This collection of clinical research professionals’ information requests answered by the FDA’s Office of Good Clinical Practice sheds light on some of the most difficult and important topics in clinical trial research.

Drugmaker’s Guide to Process Validation: Principles, Methods and Compliance

March 2, 2021
Process validation can be confusing and complicated. With this management report, you’ll be able to align your validation choices with the expectations of regulators and discover the best methods for conducting a risk analysis, creating testing and sampling procedures and interpreting test results.

Process Validation for Devicemakers: Concepts, Methods and Models

March 2, 2021
This management report walks you through each step of the validation process. It provides the information you need to make decisions along the way. And it presents validation strategies, methods and tools to use to ensure compliance.

The Preapproval Inspection: Passing the FDA’s GMP Test

February 2, 2021
Are you prepared for the FDA’s more rigorous preapproval inspection (PAI) for new drugs? The PAI goes well beyond a typical good manufacturing practices (GMP) inspection. The FDA’s objectives are highly targeted and its updated procedures are much more challenging. This report provides all the information you need to handle a PAI successfully.

The New 510(k) Pathway: A Guide to Updated Requirements

January 6, 2021
This management report explains the new rules for selecting predicate devices, changes in device classification, opportunities for pre-submission meetings with the agency, additional postmarket testing requirements and expansion of the third-party review program.

Reliability of Medical Devices: Ensuring Availability and Safety

January 6, 2021
What are the requirements for device reliability and how can you measure it? Take your devices to the next level of reliability and achieve the best in product quality with this management report.

Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

December 7, 2020
This report brings together all the guidances, statistics and instructions you need to successfully get through an FDA inspection.

New Adverse Event Reporting Procedures: A Devicemaker’s Guide to the IMDRF Code Transition

December 7, 2020
This management report provides a detailed explanation of the new set of adverse event codes and how to adapt to the changes to the FDA’s electronic submission methods and the EU’s new reporting form.

Quality Risk Management in the EU: Concepts and Compliance

November 9, 2020
This easy-to-follow reference covers all aspects of EU quality risk management: regulatory expectations, processes, methods and tools.

Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

November 9, 2020
With this management report, you’ll discover how to move a spreadsheet toward validation, determining the best ways to conform with data integrity requirements and uncovering what FDA inspectors are looking for in a validated data analysis and reporting tool.

Data Integrity for Drug and Device Manufacturers: Avoiding Breaches and Closing Gaps

November 9, 2020
This management report is your GPS for data integrity compliance. It explains what data integrity is, how to protect it, how to spot problems and what the FDA expects.

Pharmaceutical Quality Risk Management: Navigating New Regulatory Requirements

October 19, 2020
The COVID-19 pandemic is making it more difficult for pharmaceutical manufacturers to maintain production levels and meet regulatory requirements. With this report you can make your quality risk management (QRM) efforts more effective. By using our expert tips, you will be able to determine which risks you need to manage, how to consistently apply risk management principles, and ways to implement a successful QRM plan.
Previous 1 2 3 4 5 6 7 8 9 … 19 20 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • FDA Updates Smiths Medical CADD System Recall to Class I

  • Eisai’s New Alzheimer’s Drug Leqembi Hits the U.S. Market

  • Boston Scientific’s Single Use Ureteroscope Gets FDA Clearance

  • Gilead’s Trodelvy Gets Expanded Approval in Breast Cancer

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing